Track topics on Twitter Track topics that are important to you
Phone: 44 1865 405118
Fax: 44 1865 405120
Mike Evans, CEO of Oxford Gene Technology talks to Fintan Walton about OGT's new diagnostic techiques and innovative research into Lupus, Prostate and Colorectal cancers.
Oxford BioMedica said today it will partner with Bioverativ to develop and manufacture lentiviral vectors designed to treat hemophilia, through a collaboration that could generate up to $105 million-p...
A new technique for gene sequencing has produced the most complete human genome ever assembled with a single technology - the nanapore, developed by UK company Oxford Nanopore Technologies. The m...
LONDON (Reuters) - Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $1...
The deal includes a licence to use OXB's LentiVector Enabled technology and access to its industrial-scale manufacturing technology.
Affymetrix Inc. (Santa Clara, CA) has purchased a license to the Southern DNA array patents owned by Oxford Gene Technology (OGT; Oxford, England)...
UK gene cell therapy designer Oxford BioMedica’s shares jumped as much as 11.2% to 12.30 pence this…
Nightstar Therapeutics will begin the first Phase III trial for a gene therapy targeting choroideremia, a rare disorder leading to complete blindness. Nightstar will launch the first-ever Phase III t...
SUN SAVVY SOLAR SHIELD SPF 20
Neutrogena Skin Clearing blemish concealer
Colgate FLUORIDE TOOTHPASTE PROCLINICAL™
The recent introduction of a barcoding protocol for Oxford Nanopore sequencing has increased the versatility of the technology. Several bioinformatics tools have been developed to demultiplex barcoded...
Functional genomics of filamentous fungi has gradually uncovered gene information for constructing 'cell factories' and controlling pathogens. Available gene manipulation methods of filamentous fungi ...
Homology-based gene prediction is a powerful concept to annotate newly sequenced genomes. We have previously demonstrated that whole genome alignments can be utilized for accurate comparative coding g...
Over time, there has been a growing interest in the application of gene therapy within the healthcare industry as demonstrated by the nearly 3,000 clinical trials associated with gene therapy that are...
Is perinatal mortality rate higher among births born following assisted reproductive technology (ART) compared to non-ART births?
The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...
Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...
The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...
The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...
Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty
Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...
Oxford BioMedica advanced gene therapy techniques.
Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was esta...
DNA microassays consisting of in situ synthesises oligonucleotide probes.
Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...
We have published hundreds of Oxford Gene Technology news stories on BioPortfolio along with dozens of Oxford Gene Technology Clinical Trials and PubMed Articles about Oxford Gene Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Gene Technology Companies in our database. You can also find out about relevant Oxford Gene Technology Drugs and Medications on this site too.
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...